Quarterly report pursuant to Section 13 or 15(d)

Organization, Plan of Business Operations and Going Concern Consideration (Details Textual)

v3.7.0.1
Organization, Plan of Business Operations and Going Concern Consideration (Details Textual) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Dec. 31, 2016
Working Capital Deficit $ 7,600    
Stockholders' Equity Attributable to Parent (8,904)   $ (8,248)
Proceeds from Notes Payable 71 $ 875  
Long-term Line of Credit 2,900    
NSC Biotech Venture Fund I, LLC [Member]      
Proceeds from Notes Payable $ 3,000